COMPOSITION PHARMACEUTIQUE COMPRENANT LA COMBINAISON D'UN AGENT ANTI-ARTHRITIQUE ET D'UN AGENT INHIBITEUR DE L'INTERLEUKINE 1, UTILE POUR LE CONTRÔLE ET LE TRAITEMENT DE L'OSTÉOARTHROSE ET DE MALADIES ASSOCIÉES
The invention relates to a pharmaceutical composition comprising the synergic combination of an antiarthritic agent know as chondroitin sulphate and an interleukin-1 inhibiting agent know as diacerein, as well as pharmaceutically acceptable excipients, which are formulated in a single dosage unit to be administered orally. The composition, which is used to control and treat osteoarthritis and related diseases, provides an improved therapeutic effect and faster pharmacological action in less time, as well as reducing pain and inflammation and altering the course of the structural articular cartilage disease, with reduced risk of severe complications and/or side effects.
